How will we solve cancer's biggest challenges?

Cancer will affect We all during OUR Lives, if through OUR own diagnostics Or those of love those. It is A do Teacher Caroline Dive, director of THE CRUK National Biomarker Center, knows all Also GOOD.

"Almost A In two of We will get cancer In OUR Lives. Walk through THE Christie Hospital In Manchester, THE the biggest cancer hospital In Europe, I am surrounded by THE the reasons Why I TO DO What I TO DO," She said. And given Diving family history, It is clear has see Or her tireless motivation come from.

Diving grandfather deceased Since brain cancer Before She was born. Her mother has suffered surgery on A endometrium tumor, And her father was treaty For colon cancer. He pass far last year has 95 years, following A further diagnostic of cancer.

He was her father that inspired Dive has pursue A career In science. A degree In pharmacy directed on has PhD studies In Cambridge, And her career has taken A number of twists and turns And turns Since. But A constant has has been THE support of Cancer Research UNITED KINGDOM And It is philanthropic the partners, which to have finance her work For more that 35 years.

Dive has witnessed THE radical transformation of cancer care, Since THE phasing out of THE First of all chemotherapeutic drugs – nitrogen mustards, which were initially developed For chemical war during World War Two – through has THE development of avant-garde target treatments as immunotherapies. More recently, she is has been drawn has biomarkers.

“Biomarker East A word, but he covers A plethora of different kinds of tests that enable clinicians has manage A the patients individual cancer In THE best path possible," She explain. These tests could indicate A the person risk of get cancer, detect early panels of THE disease, Or to show THE aggressiveness of A cancer.

THE impact biomarkers will to have on the patients' care can't be underrated. Doctors will be able has get more information, faster, has determine THE best treatment plan For each individual.

And he will stop a few the patients Since in progress useless interventions Or treatments that could cause pain Or discomfort.

"We to have has learn how has manage cancer. And that will mean We can give the patients longer with their love those, And A GOOD quality of life."

"We are functioning on A test that predicted WHO East going has answer has immunotherapy, For example," Dive explain. “Immunotherapy can work Really, Really GOOD In a few the patients, but not all. THE last thing You to want East has give immunotherapy has A patient Or he has No chance of functioning, but Or he could cause a few instead unpleasant side effects And be enough toxic."

These revolutionary tests brand A crucial stage In manufacturing personalized medicine A reality, THANKS has Cancer Research from the United Kingdom in progress commitment has transform THE outlook For people affected by THE disease. "We to have has learn how has manage cancer. And that will mean We can give the patients longer with their love those, And A GOOD quality of life," said Dive in.

More that 100 people are functioning on innovative research has THE CRUK National Biomarker Center, playing A integral part In A global network of outstanding scientist research. “Biomarker research East in progress enough A revolution RIGHT NOW And were with caution optimistic that For example, new blood tests, called liquid biopsies, that are easily repeatable, could TO DO A huge impact In improvement patient care. But There is always A huge Rising of work has be do has TO DO Of course these blood tests are GOOD enough For routine to use In THE clinical. For Of course It is A extremely exciting time has be A cancer searcher," She said.